Heart valve surgery infection fight: two drugs vs. one in major trial
NCT ID NCT07442357
Summary
This large trial in Denmark aims to find the best antibiotic strategy to prevent serious infections after a minimally invasive heart valve replacement procedure called TAVI. It will compare giving patients one standard antibiotic versus a combination of two antibiotics right before their procedure. The main goal is to see if the two-drug approach is better at preventing bloodstream infections or death within six months after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark
Conditions
Explore the condition pages connected to this study.